(Q45830455)

16 December 2017

title

The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man. (English)

1 reference

16 December 2017

1 reference

3

Gerken G

1 reference

Karl-Hermann Meyer zum Büschenfelde

16 December 2017

6

object named as

Meyer zum Büschenfelde KH

1 reference

16 December 2017

author name string

Hess G

1

1 reference

16 December 2017

Gerlich W

2

1 reference

16 December 2017

Manns M

4

1 reference

16 December 2017

Hütteroth TH

5

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 July 1987

1 reference

16 December 2017

published in

Hepatology

1 reference

16 December 2017

volume

7

1 reference

16 December 2017

issue

4

1 reference

16 December 2017

page(s)

704-708

1 reference

16 December 2017

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

Biochemical pathways in interferon-action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

Hemagglutination and immunofluorescence studies on polymerized human serum albumin binding activity in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070414

7 January 2021

Identifiers

DOI

10.1002/HEP.1840070414

1 reference

16 December 2017

1 reference

16 December 2017